Anti-dementia drugs treatment

Researchers from pharmaceutical group Pfizer have claimed some older people are failing to get fair access to anti-dementia drugs because of where they live. The research claimed some areas were spending four times as much as others on such medicines. Some areas of the country are spending £8 or more on anti-dementia drugs per head…